Cyma Builders Launches North Carolina EPCM Portfolio with Exela

Exela Pharma Sciences, LLC has selected Cyma Builders as the EPCM lead for multiple facility projects in Lenoir, NC. Exela, a developer and manufacturer of proprietary and generic sterile injectable products, first engaged Cyma in summer 2024 for a new Syringe Manufacturing facility.

The project involves converting a 120,000 SF former furniture and fabric manufacturing plant into a state-of-the-art syringe production facility. The initial phase will include two syringe manufacturing lines, two molding rooms, and supporting spaces such as labs, offices, gowning and locker rooms, a break room, and a warehouse. Future expansion plans include up to six syringe manufacturing lines. This fast-track project aims to launch operations in early 2026.

Beyond the new facility, Exela has also tasked Cyma with leading major infrastructure upgrades, filling line improvements, and building expansions across other Lenoir sites. Cyma is currently advancing through the design phase, with construction staffing planned for the second half of 2025 and into 2026.